Arch Pharmalabs logo

524729 - Arch Pharmalabs Share Price

₹7.5 0.0  0.0%

Last Trade - 11/11/03

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £175.5m
Position in Universe th / 3096
Bullish
Bearish
Unlock 524729 Revenue
Momentum
Relative Strength (%)
1m +0.20%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2007 2008 2009 2010 2011 2012 2013E 2014E CAGR / Avg
3,641 5,424 9,832 11,621 14,318 17,928 +37.6%
+30.6 +27.2 -22.8 +82.6 +45.8 +12.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2012, ArchPharmalabs Ltd revenues increased 25% to RS17.93B. Netincome increased 20% to RS1B. Revenues reflect Rest ofWorld segment increase of 54% to RS9.49B, India segmentincrease of 2% to RS8.21B. Net income was partially offsetby Interest and Finance Charges increase of 48% to RS2.46B(expense), Provisions for Employees increase of 32% toRS1.01B (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

524729 Revenue Unlock 524729 Revenue

Net Income

524729 Net Income Unlock 524729 Revenue

Normalised EPS

524729 Normalised EPS Unlock 524729 Revenue

PE Ratio Range

524729 PE Ratio Range Unlock 524729 Revenue

Dividend Yield Range

524729 Dividend Yield Range Unlock 524729 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
524729 EPS Forecasts Unlock 524729 Revenue
Profile Summary

Arch Pharmalabs Ltd. is a pharmaceutical company. The Company is engaged in Products and Services business. Its Products business comprises manufacture and sale of active pharmaceutical ingredients (APIs) and Intermediates to generic pharmaceutical companies in both domestic and international markets. It offers Contract Research and Manufacturing Services (CRAMS). Its products include Atorvastatin calcium, which is a lipid lowering agent; Amlodipine besylate, which is a calcium channel blocker; Clopidogrel bisulphate (Form I and Form II), which is an anti-platelet agent, and Isosorbide-5-mononitrate, which is an anti anginal agent, among others. The Company has developed capabilities to provide a range of CRAMS starting from route selection/process development/optimization, analytical development, stability studies, safety studies, scale-up to technology transfer/clinical-trial manufacturing to commercial manufacturing to suit the United States/Europe regulatory requirements.

Directors
Last Annual March 31st, 2012
Last Interim January 1st, 1970
Incorporated April 2, 1993
Public Since October 17, 1994
No. of Shareholders: 18,699
No. of Employees: 2,355
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Bombay Stock Exchange
Shares in Issue 24,784,022
Free Float (0.0%)
Eligible for
ISAs
SIPPs
524729 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 524729
Upcoming Events for 524729
Frequently Asked Questions for Arch Pharmalabs
What is the Arch Pharmalabs share price?

As of 11/11/03, shares in Arch Pharmalabs are trading at ₹7.5, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Arch Pharmalabs share price performed this year?

Shares in Arch Pharmalabs are currently trading at ₹7.5 and the price has moved by 0.552k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Arch Pharmalabs price has moved by 0.390k% over the past year.

What are the analyst and broker recommendations for Arch Pharmalabs?

There are no analysts currently covering Arch Pharmalabs.

When will Arch Pharmalabs next release its financial results?

It is not known when Arch Pharmalabs will next release financial results.

What is the Arch Pharmalabs dividend yield?

Arch Pharmalabs does not currently pay a dividend.

Does Arch Pharmalabs pay a dividend?

Arch Pharmalabs does not currently pay a dividend.

When does Arch Pharmalabs next pay dividends?

Arch Pharmalabs does not currently pay a dividend.

How do I buy Arch Pharmalabs shares?

To buy shares in Arch Pharmalabs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Arch Pharmalabs?

Shares in Arch Pharmalabs are currently trading at ₹7.5, giving the company a market capitalisation of £n/a.

Where are Arch Pharmalabs shares listed? Where are Arch Pharmalabs shares listed?

Here are the trading details for Arch Pharmalabs:

Country of listing: India
Exchange: BSE
Ticker Symbol: 524729
What kind of share is Arch Pharmalabs?

We were not able to load our ranking data for Arch Pharmalabs

Is there a Arch Pharmalabs share price forecast 2021?

We were not able to load any forecast data for Arch Pharmalabs.

How can I tell whether the Arch Pharmalabs share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arch Pharmalabs. Over the past six months, the relative strength of its shares against the market has been 79.73%. At the current price of ₹7.5, shares in Arch Pharmalabs are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Arch Pharmalabs PE Ratio?

We were not able to find PE ratio data for Arch Pharmalabs.

Who are the key directors of Arch Pharmalabs?

We were unable to find the directors for Arch Pharmalabs.

Who are the major shareholders of Arch Pharmalabs?

Here are the top five shareholders of Arch Pharmalabs based on the size of their shareholding:

Similar to 524729
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.